Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000527707 | SCV000628512 | benign | Neurofibromatosis, type 1 | 2024-08-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000764107 | SCV000895075 | uncertain significance | Neurofibromatosis, familial spinal; Juvenile myelomonocytic leukemia; Neurofibromatosis, type 1; Neurofibromatosis-Noonan syndrome; Café-au-lait macules with pulmonary stenosis | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002448634 | SCV001181553 | likely benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2017-12-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001574886 | SCV001801773 | uncertain significance | not provided | 2022-09-23 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 28977029, 25486365, 2121369) |
Sema4, |
RCV001020116 | SCV002527503 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-09-30 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001574886 | SCV005624568 | uncertain significance | not provided | 2024-02-27 | criteria provided, single submitter | clinical testing |